Page last updated: 2024-08-22

glucosamine and miglitol

glucosamine has been researched along with miglitol in 109 studies

Research

Studies (109)

Timeframe	Studies, this research(%)	All Research%
pre-1990	31 (28.44)	18.7374
1990's	46 (42.20)	18.2507
2000's	30 (27.52)	29.6817
2010's	2 (1.83)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Frydas, A; Ladas, SD; Papadopoulos, A; Raptis, SA	1
Dimitriadis, G; Raptis, S	1
Kingma, PJ; Menheere, PP; Nieuwenhuijzen Kruseman, AC; Sels, JP	1
Ahrens, K; Arends, J; Lübke, D; Willms, B	1
DeBouno, JF; Michaelis, OE; Szepesi, B; Tulp, OL	1
Creutzfeldt, W; Lamberts, R; Lembcke, B; Wöhler, J	1
Creutzfeldt, W; Ebert, R; Fölsch, UR; Gatzemeier, W; Lembcke, B; Siegel, E	1
Holman, RR; Steemson, J; Turner, RC	1
Toeller, M	1
Inoue, S; Shishido, T	1
Alexopoulos, E; Dimitriadis, G; Ganotakis, M; Hatziagellaki, E; Komesidou, V; Kordonouri, O; Raptis, S	1
Bloom, SR; Requejo, F; Uttenthal, LO	1
Berzin, M; Diamond, TH; Griffiths, RF; Kalk, WJ; Osler, CE; Smit, AM; Wing, J	1
Foukaridis, GN; Joubert, PH; Venter, HL	1
Heagerty, AM; MacIver, DH; McNally, PG; Ollerenshaw, JD; Sheldon, TA	1
Creutzfeldt, W; Diederich, M; Fölsch, UR; Lembcke, B	1
Gerok, W; Giffhorn-Katz, S; Gross, V; Heinrich, PC; Katz, NR; Kreisel, W; Ludolph, D	1
Reuser, AJ; van Dongen, JM; Wisselaar, HA	1
Madar, Z	2
Gray, RS; Hillman, RJ; Scott, M	1
Klauser, RM; Prager, RJ; Schernthaner, G; Schnack, C; Schneider, BG; Winkler, J	1
Heinz, G; Komjati, M; Korn, A; Waldhäusl, W	1
Goda, T; Koldovský, O; Lee, SM; Samulitis, BK	1
Bollen, M; Stalmans, W; Vandebroeck, A	1
Scott, AR; Tattersall, RB	1
Alberti, KG; Samad, AH; Taylor, R; Ty Willing, TS	1
Holt, PR; Kotler, DP; Thea, D; Yang, MY	1
Federlin, K; Hillebrand, I; Laube, H	1
Dimitriadis, G; Hatziagelaki, E; Hillebrand, I; Ladas, S; Linos, A; Raptis, S	1
Cañizo, JF; Hillebrand, I; Navascués, I; Sabán, J; Serrano-Rios, M	1
Gerich, JE; Kennedy, FP	2
Gerard, J; Hillebrand, I; Lefèbvre, PJ	1
Creutzfeldt, W; Fölsch, UR; Lembcke, B; Löser, C; Wöhler, J	1
Gerich, JE; Heiling, V; Kennedy, FP; Miles, JM	1
Boehme, K; Graefe, KH; Hillebrand, I; Wehling, K	1
Cauderay, M; Felber, JP; Hillebrand, I; Jéquier, E; Tappy, L; Temler, E	1
Bam, WJ; Joubert, PH; Manyane, N	1
Dimitriadis, G; Halvatsiotis, P; Hatziagelaki, E; Hillebrand, I; Ladas, S; Mitrakou, A; Raptis, A; Raptis, S	1
Luger, A; Röggla, G; Schernthaner, G; Schnack, C	1
Anastasopoulou, K; Frangaki, D; Hillebrand, I; Katsilambros, N; Marangos, M; Philippides, P; Protopapas, J; Siskoudis, P; Toskas, A; Xefteri, H	1
Arends, J; Willms, BH	1
Bopape, ML; Foukaridis, GN; Joubert, PH	1
Bachmann, W; Hillebrand, I; Lotz, N; Rinninger, F	1
Barker, HM; Bowey, EA; Canfield, JE; Taylor, RH	1
Creutzfeldt, W; Fölsch, UR; Lembcke, B	1
Bozza, M; Corgiat-Mansin, L; Cravero, F; Giorda, C; Marena, S; Pagano, G; Rossi, CM	1
Lundquist, I; Salehi, A	1
Reuser, AJ; Wisselaar, HA	1
Branolte, JH; Kingma, PJ; Menheere, PP; Nieuwenhuijzen Kruseman, AC; Sels, JP; Wolffenbuttel, BH	1
Coniff, RF; Hoogwerf, BJ; Johnston, PS; Krol, A; Pi-Sunyer, FX; Santiago, JV	1
Tattersall, R	1
DeBouno, JF; Michaelis, OE; Tulp, OL	1
Johnson, AB; Taylor, R	1
Duursema, L; Groenewoud, G; Hundt, HK; Middle, MV; Müller, FO; Schall, R	1
Menheere, PP; Nauta, JJ; Nieuwenhuijzen Kruseman, AC; Sels, JP; Wolffenbuttel, BH	1
Campillo, JE; Martinez, IM; Nieto, M; Ropero, MF; Tormo, MA	2
Berlin, C; Feig, PU; Petzinna, D; Ratzmann, KP; Rybka, J; Schernthaner, G; Segal, P	1
Ahr, HJ; Boberg, M; Brendel, E; Krause, HP; Steinke, W	1
Coniff, RF; Davidson, JA; Feig, PU; Haffner, SM; Johnston, PS; Krol, A	1
Coniff, RF; Feig, PU; Johnston, PS; Kelley, DE; Krol, A; Mooradian, AD	1
Coniff, RF; Johnston, PS; Lebovitz, HE; Munera, CL; Raskin, P; Simonson, DC	1
Bauer, RJ; Mitrakou, A; Raptis, AE; Raptis, SA; Schulz, H; Tountas, N	1
Chiasson, JL; Rabasa-Lhoret, R	1
Lardinois, CK	1
Mooradian, AD; Thurman, JE	1
Axen, KV; Li, X; Sclafani, A	1
Dolphin, PJ; Graham, SE; Russell, JC	1
Andres, E; Blicklé, JF; Brogard, JM	1
Arai, M; Fujiwara, H; Fujiwara, T; Hashimoto, K; Kariya, T; Kawasaki, M; Minatoguchi, S; Nishida, Y; Takemura, G; Uno, Y	1
Riddle, MC	1
Scott, LJ; Spencer, CM	1
Stadler, HJ	1
Fehmann, HC	4
Kuritzky, L; Quillen, DM; Samraj, G	1
Carlson, RF	1
Chiou, WL; Chung, SM; Jeong, HY; Ma, C; Wu, TC	1
Baker, DE; Campbell, LK; Campbell, RK	1
Huijberts, MS; Sels, JP; Wolffenbuttel, BH	1
Hanefeld, M; Naditch, L; Raptis, SA; Rybka, J; Schernthaner, G; Standl, E	1
Chiasson, JL; Naditch, L	1
Laws, A	1
Arai, M; Chen, XH; Fujiwara, H; Hashimoto, K; Hashimoto, Y; Minatoguchi, S; Takemura, G; Uno, Y; Wang, N	1
Maislos, M; Rybka, J; Schernthaner, G; Segal, P; Van Gaal, L	1
Lefèbvre, PJ; Scheen, AJ	1
Neye, H	1
Drent, ML; Hoenderdos, EB; Jonker, JJ; Tollefsen, AT; van der Veen, EA; van Heusden, FH	1
Horowitz, M; Lee, A; Morley, JE; Patrick, P; Wishart, J	1
Artés, M; Benito, P; Faure, E; García-Mayor, R; López, JS; Mesa, J; Pallardo, LF; Puig-Domingo, M; Ravella, R	1
Deppenmeier, U; Hoffmeister, M; Prust, C	1
Chawla, S; Takiya, L	1
Fischer, S; Hanefeld, M	1
Scheen, AJ	1
Aller, R; Conde Valentín, R; de Luis Román, DA; del Pozo García, E; Romero Bobillo, E	1
Haslbeck, M; Jakob, S; Kellerer, M; Linn, T	1
Arai, M; Chen, X; Fujiwara, H; Fujiwara, T; Lu, C; Minatoguchi, S; Takemura, G; Uno, Y; Wang, N	1
Akkermans, RP; Lucassen, PL; Rutten, GE; Van de Laar, FA; Van de Lisdonk, EH; Van Weel, C	1
Arai, M; Chen, XH; Fujiwara, H; Hashimoto, K; Lu, C; Minatoguchi, S; Takemura, G; Uno, Y; Wang, N	1
Hayashi, I; Kuboyama, N; Yamaguchi, T	1
Boosi, R; Kandikere, VN; Maurya, S; Mudigonda, K; Nirogi, RV; Shukla, M; Yerramilli, A	1
Adachi, I; Asano, N; Cha, JK; Fleet, GW; Hirokami, Y; Hollinshead, J; Kato, A; Kiappes, JL; Kinami, K; Miyawaki, S; Molyneux, RJ; Nash, RJ; Tsuji, Y; Zitzmann, N	1
Li, M; Li, XL; Liu, YX; Peng, YT; Wang, KR; Yang, JX; Zhang, HX	1

Reviews

19 review(s) available for glucosamine and miglitol

Article	Year
alpha-Glucosidase inhibition in the treatment of diabetes mellitus. Hormone and metabolic research. Supplement series, 1992, Volume: 26 Topics: 1-Deoxynojirimycin; Acarbose; Diabetes Mellitus; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Reference Values; Trisaccharides	1992
[Inhibitors of alpha-glucosidase]. Journees annuelles de diabetologie de l'Hotel-Dieu, 1991 Topics: 1-Deoxynojirimycin; Acarbose; Blood Glucose; Carbohydrate Metabolism; Clinical Trials as Topic; Diabetes Mellitus; Digestion; Glucosamine; Glycoside Hydrolase Inhibitors; Imino Pyranoses; Insulin; Triglycerides; Trisaccharides	1991
An evaluation of the potential side-effects of alpha-glucosidase inhibitors used for the management of diabetes mellitus. European journal of clinical investigation, 1994, Volume: 24 Suppl 3 Topics: 1-Deoxynojirimycin; Acarbose; Administration, Oral; Animals; Blood Glucose; Carbohydrate Sequence; Contraindications; Diabetes Mellitus; Diabetic Nephropathies; Glucosamine; Glycogen; Glycogen Storage Disease; Glycoproteins; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Molecular Sequence Data; Sucrase-Isomaltase Complex; Trisaccharides	1994
Alpha-glucosidase inhibition as an adjunct to the treatment of type 1 diabetes. Diabetic medicine : a journal of the British Diabetic Association, 1993, Volume: 10, Issue:8 Topics: 1-Deoxynojirimycin; Acarbose; Blood Glucose; Diabetes Mellitus, Type 1; Eating; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemia; Imino Pyranoses; Trisaccharides	1993
Potential of alpha-glucosidase inhibitors in elderly patients with diabetes mellitus and impaired glucose tolerance. Drugs & aging, 1998, Volume: 13, Issue:2 Topics: 1-Deoxynojirimycin; Acarbose; Aged; Body Weight; Cognition; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucosamine; Glucose Intolerance; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Trisaccharides	1998
Type 2 diabetes: glycemic targets and oral therapies for older patients. Geriatrics, 1998, Volume: 53, Issue:11 Topics: 1-Deoxynojirimycin; Acarbose; Age Factors; Aged; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Glucosamine; Humans; Hypoglycemic Agents; Imino Pyranoses; Metformin; Piperidines; Sulfonylurea Compounds; Trisaccharides	1998
Drug therapy of postprandial hyperglycaemia. Drugs, 1999, Volume: 57, Issue:1 Topics: 1-Deoxynojirimycin; Acarbose; Amyloid; Carbamates; Diabetes Mellitus; Enzyme Inhibitors; Glucosamine; Glyburide; Humans; Hyperglycemia; Hypoglycemic Agents; Imino Pyranoses; Inositol; Insulin; Insulin Lispro; Islet Amyloid Polypeptide; Piperidines; Postprandial Period; Trisaccharides	1999
[Current status of the treatment of type 2 diabetes mellitus. Alpha-glucosidase inhibitors]. La Revue de medecine interne, 1999, Volume: 20 Suppl 3 Topics: 1-Deoxynojirimycin; Acarbose; Blood Glucose; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Disaccharides; Drug Combinations; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hydrolysis; Hypoglycemic Agents; Imino Pyranoses; Insulin; Polysaccharides	1999
Oral pharmacologic management of type 2 diabetes. American family physician, 1999, Volume: 60, Issue:9 Topics: 1-Deoxynojirimycin; Acarbose; Administration, Oral; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Metformin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; United States	1999
Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus. Drugs, 2000, Volume: 59, Issue:3 Topics: 1-Deoxynojirimycin; Biological Availability; Blood Glucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Glucosamine; Glucosidases; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Imino Pyranoses; Intestinal Absorption; Liver; Postprandial Period; Randomized Controlled Trials as Topic; Tissue Distribution	2000
Improving management of type 2 diabetes mellitus: 1. alpha-Glucosidase inhibitors. Hospital practice (1995), 1999, Sep-15, Volume: 34, Issue:10 Topics: 1-Deoxynojirimycin; Acarbose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Imino Pyranoses	1999
Miglitol: assessment of its role in the treatment of patients with diabetes mellitus. The Annals of pharmacotherapy, 2000, Volume: 34, Issue:11 Topics: 1-Deoxynojirimycin; Aged; Animals; Diabetes Mellitus; Drug Administration Schedule; Drug Interactions; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Intestinal Absorption; Middle Aged; Randomized Controlled Trials as Topic	2000
Miglitol, a new alpha-glucosidase inhibitor. Expert opinion on pharmacotherapy, 1999, Volume: 1, Issue:1 Topics: 1-Deoxynojirimycin; Animals; Clinical Trials as Topic; Diabetes Mellitus; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses	1999
[Reducing postprandial glucose levels. Glucosidase antagonists]. Pharmazie in unserer Zeit, 2002, Volume: 31, Issue:3 Topics: 1-Deoxynojirimycin; Acarbose; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucosamine; Glucosidases; Humans; Hypoglycemic Agents; Imino Pyranoses; Postprandial Period	2002
Biochemistry and biotechnological applications of Gluconobacter strains. Applied microbiology and biotechnology, 2002, Volume: 60, Issue:3 Topics: 1-Deoxynojirimycin; Acetic Acid; Ascorbic Acid; Biotechnology; Carbohydrate Metabolism; Genome, Bacterial; Gluconates; Gluconobacter; Glucosamine; Hydrogen-Ion Concentration; Imino Pyranoses	2002
Therapeutic options for the management of type 2 diabetes mellitus. The American journal of managed care, 2002, Volume: 8, Issue:11 Topics: 1-Deoxynojirimycin; Adult; Diabetes Mellitus, Type 2; Disease Management; Education, Medical, Continuing; Education, Pharmacy, Continuing; Glucosamine; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Insulin Aspart; Managed Care Programs; Metformin; Thiazoles; Thiazolidinediones; United States	2002
Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus? Drugs, 2003, Volume: 63, Issue:10 Topics: 1-Deoxynojirimycin; Acarbose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Inositol; Randomized Controlled Trials as Topic	2003
[Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy]. MMW Fortschritte der Medizin, 2003, Dec-18, Volume: 145, Issue:51-52 Topics: 1-Deoxynojirimycin; Acarbose; Aged; Blood Glucose; Carbamates; Contraindications; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Fasting; Follow-Up Studies; Germany; Glucosamine; Glyburide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Imino Pyranoses; Insulin; Metformin; Middle Aged; Nateglinide; Obesity; Patient Compliance; Phenylalanine; Pioglitazone; Piperidines; Practice Guidelines as Topic; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Time Factors	2003
Alpha-glucosidase inhibitors for type 2 diabetes mellitus. The Cochrane database of systematic reviews, 2005, Apr-18, Issue:2 Topics: 1-Deoxynojirimycin; Acarbose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Inositol; Randomized Controlled Trials as Topic	2005

Trials

47 trial(s) available for glucosamine and miglitol

Article	Year
Effects of alpha-glucosidase inhibitors on mouth to caecum transit time in humans. Gut, 1992, Volume: 33, Issue:9 Topics: 1-Deoxynojirimycin; Acarbose; Adolescent; Adult; Breath Tests; Gastrointestinal Transit; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hydrogen; Imino Pyranoses; Male; Stimulation, Chemical; Time Factors; Trisaccharides	1992
alpha-Glucosidase inhibition by miglitol in NIDDM patients. Diabetes care, 1992, Volume: 15, Issue:4 Topics: 1-Deoxynojirimycin; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diet, Diabetic; Dietary Carbohydrates; Fatty Acids, Nonesterified; Female; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Male; Middle Aged	1992
[Delayed absorption of carbohydrates in the therapy of Type II diabetes: comparison between dietary (Muesli) and pharmacological (Alpha-glucosidase inhibition) modification]. Schweizerische medizinische Wochenschrift, 1991, Sep-21, Volume: 121, Issue:38 Topics: 1-Deoxynojirimycin; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diet, Diabetic; Dietary Carbohydrates; Dietary Fiber; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Intestinal Absorption; Middle Aged	1991
Inhibition of glycemic and hormonal responses after repetitive sucrose and starch loads by different doses of the alpha-glucosidase inhibitor miglitol (BAY m 1099) in man. Pharmacology, 1991, Volume: 43, Issue:6 Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Dietary Carbohydrates; Double-Blind Method; Gastric Inhibitory Polypeptide; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Male; Starch; Sucrose	1991
Post-prandial glycaemic reduction by an alpha-glucosidase inhibitor in type 2 diabetic patients with therapeutically attained basal normoglycaemia. Diabetes research (Edinburgh, Scotland), 1991, Volume: 18, Issue:4 Topics: 1-Deoxynojirimycin; Biomarkers; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Diet, Diabetic; Eating; Female; Fructosamine; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Hexosamines; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Insulin, Long-Acting; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Reference Values; Time Factors; Triglycerides	1991
Effects of alpha-glucosidase inhibition and viscous fibre on diabetic control and postprandial gut hormone responses. Diabetic medicine : a journal of the British Diabetic Association, 1990, Volume: 7, Issue:6 Topics: 1-Deoxynojirimycin; Adult; Aged; Biomarkers; Blood Glucose; Cholesterol; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dietary Fiber; Double-Blind Method; Eating; Female; Fructosamine; Galactans; Glucosamine; Glycoside Hydrolase Inhibitors; Hexosamines; Humans; Imino Pyranoses; Male; Mannans; Middle Aged; Plant Gums; Random Allocation; Triglycerides	1990
The acute effects of glucosidase inhibition on post-meal glucose increments in insulin-dependent diabetics. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1990, Mar-17, Volume: 77, Issue:6 Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Male; Middle Aged; Randomized Controlled Trials as Topic; Time Factors	1990
The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism? British journal of clinical pharmacology, 1990, Volume: 30, Issue:3 Topics: 1-Deoxynojirimycin; Acarbose; Administration, Oral; Adult; Blood Glucose; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Male; Trisaccharides	1990
The effect of short chain fatty acid supplementation on membrane electrolyte transport and blood pressure. Journal of human hypertension, 1990, Volume: 4, Issue:5 Topics: 1-Deoxynojirimycin; Adult; Biological Transport; Blood Pressure; Double-Blind Method; Electrolytes; Erythrocyte Membrane; Erythrocytes; Fatty Acids, Volatile; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Linoleic Acid; Linoleic Acids; Male; Oleic Acid; Oleic Acids; Palmitic Acids; Potassium; Sodium	1990
Postprandial glycemic control, hormonal effects and carbohydrate malabsorption during long-term administration of the alpha-glucosidase inhibitor miglitol. Digestion, 1990, Volume: 47, Issue:1 Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Breath Tests; Dietary Carbohydrates; Double-Blind Method; Gastric Inhibitory Polypeptide; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hydrogen; Imino Pyranoses; Insulin; Malabsorption Syndromes; Male; Time Factors	1990
Effect of alpha-glucosidase inhibition on glucose profiles in insulin dependent diabetes. Diabetes research (Edinburgh, Scotland), 1989, Volume: 10, Issue:2 Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 1; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Middle Aged; Triglycerides	1989
Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients. Diabetes care, 1989, Volume: 12, Issue:8 Topics: 1-Deoxynojirimycin; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Liver; Male; Middle Aged	1989
Reduction of postprandial blood glucose by the alpha-glucosidase inhibitor Miglitol (BAY m 1099) in type II diabetes. European journal of clinical pharmacology, 1989, Volume: 37, Issue:1 Topics: 1-Deoxynojirimycin; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diet; Dose-Response Relationship, Drug; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Middle Aged; Time Factors	1989
Alpha glucosidase inhibition in the treatment of non-insulin-dependent diabetes mellitus. Diabetic medicine : a journal of the British Diabetic Association, 1988, Volume: 5, Issue:1 Topics: 1-Deoxynojirimycin; Adult; Aged; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Intestinal Absorption; Middle Aged; Random Allocation	1988
Effects of BAYm 1099, new alpha-glucosidase inhibitor, on acute metabolic responses and metabolic control in NIDDM over 1 mo. Diabetes care, 1988, Volume: 11, Issue:4 Topics: 1-Deoxynojirimycin; 3-Hydroxybutyric Acid; Alanine; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Eating; Fatty Acids, Nonesterified; Female; Glucosamine; Glycerol; Glycoside Hydrolase Inhibitors; Humans; Hydroxybutyrates; Hypoglycemic Agents; Imino Pyranoses; Insulin; Lactates; Male; Middle Aged; Pyruvates	1988
Intestinal and metabolic responses to an alpha-glucosidase inhibitor in normal volunteers. Metabolism: clinical and experimental, 1988, Volume: 37, Issue:12 Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Breath Tests; Feces; Female; Gastric Inhibitory Polypeptide; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hydrogen; Imino Pyranoses; Insulin; Intestinal Mucosa; Intestines; Male	1988
Effects of prolonged administration of two new alpha-glucosidase inhibitors on blood glucose control, insulin requirements and breath hydrogen excretion in patients with insulin-dependent diabetes mellitus. European journal of clinical investigation, 1988, Volume: 18, Issue:1 Topics: 1-Deoxynojirimycin; Adult; Anti-Bacterial Agents; Blood Glucose; Breath Tests; Diabetes Mellitus, Type 1; Drug Administration Schedule; Glucosamine; Humans; Hydrogen; Imino Pyranoses; Insulin; Male	1988
Effect of two new alpha-glucosidase inhibitors in insulin-dependent diabetic patients. Diabetes research and clinical practice, 1988, Jan-07, Volume: 4, Issue:2 Topics: 1-Deoxynojirimycin; Adult; Diabetes Mellitus, Type 1; Diet; Double-Blind Method; Female; Glucosamine; Glucosidases; Humans; Hyperglycemia; Hypoglycemia; Imino Pyranoses; Insulin; Male; Random Allocation	1988
A new alpha-glucosidase inhibitor (Bay-m-1099) reduces insulin requirements with meals in insulin-dependent diabetes mellitus. Clinical pharmacology and therapeutics, 1987, Volume: 42, Issue:4 Topics: 1-Deoxynojirimycin; Anti-Bacterial Agents; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Dietary Carbohydrates; Eating; Female; Glucosamine; Humans; Imino Pyranoses; Insulin; Male; Random Allocation	1987
Assessment of the clinical efficacy and tolerance of two new alpha-glucosidase inhibitors in insulin-treated diabetics. International journal of clinical pharmacology, therapy, and toxicology, 1987, Volume: 25, Issue:9 Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Body Weight; Diabetes Mellitus; Drug Tolerance; Fatty Acids, Nonesterified; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Male; Middle Aged	1987
The effect of two new alpha-glucosidase inhibitors on metabolic responses to a mixed meal in normal volunteers. Clinical and experimental pharmacology & physiology, 1987, Volume: 14, Issue:8 Topics: 1-Deoxynojirimycin; Adult; Anti-Bacterial Agents; Blood Glucose; Female; Food; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Male; Triglycerides	1987
The effect of new alpha-glucosidase inhibitors (BAY m 1099 and BAY o 1248) on meal-stimulated increases in glucose and insulin levels in man. Klinische Wochenschrift, 1986, Apr-15, Volume: 64, Issue:8 Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Clinical Trials as Topic; Dose-Response Relationship, Drug; Glucosamine; Glucosidases; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Male; Middle Aged; Random Allocation	1986
Effect of alpha-glycohydrolase inhibitors (Bay m1099 and Bay o1248) on sucrose metabolism in normal men. Metabolism: clinical and experimental, 1986, Volume: 35, Issue:5 Topics: 1-Deoxynojirimycin; Administration, Oral; Adult; Blood Glucose; Breath Tests; Fatty Acids, Nonesterified; Glucosamine; Humans; Hydrogen; Imino Pyranoses; Insulin; Lipids; Male; Pulmonary Gas Exchange; Sucrose	1986
Effects of two new alpha-glucosidase inhibitors on glycemic control in patients with insulin-dependent diabetes mellitus. Klinische Wochenschrift, 1986, May-02, Volume: 64, Issue:9 Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Breath Tests; Clinical Trials as Topic; Deuterium; Diabetes Mellitus, Type 1; Double-Blind Method; Glucosamine; Humans; Imino Pyranoses; Insulin; Insulin Infusion Systems; Male; Random Allocation	1986
Effects of the alpha-glucosidase inhibitor 1 desoxynojirimycin (Bay m 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients. European journal of clinical pharmacology, 1986, Volume: 30, Issue:4 Topics: 1-Deoxynojirimycin; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Eating; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Male; Middle Aged; Obesity; Pancreatic Hormones	1986
A double-blind study on the efficacy and tolerance of a new alpha-glucosidase inhibitor in type-2 diabetics. Arzneimittel-Forschung, 1986, Volume: 36, Issue:7 Topics: 1-Deoxynojirimycin; Adult; Aged; Anti-Bacterial Agents; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Tolerance; Female; Glucosamine; Humans; Imino Pyranoses; Male; Middle Aged; Random Allocation	1986
Smoothing effect of a new alpha-glucosidase inhibitor BAY m 1099 on blood glucose profiles of sulfonylurea-treated type II diabetic patients. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1986, Volume: 18, Issue:11 Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Male; Middle Aged; Sulfonylurea Compounds	1986
[Miglitol in the treatment of the insulin-dependent diabetic patient. Improved metabolic control and excellent tolerance]. Fortschritte der Medizin, 1987, Jul-30, Volume: 105, Issue:22 Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Diabetes Mellitus, Type 1; Glucosamine; Glycated Hemoglobin; Humans; Imino Pyranoses	1987
Comparison of miglitol and glibenclamide in diet-treated type 2 diabetic patients. Diabete & metabolisme, 1995, Volume: 21, Issue:3 Topics: 1-Deoxynojirimycin; Blood Glucose; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Method; Enzyme Inhibitors; Female; Glucosamine; Glyburide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Male; Middle Aged; Multivariate Analysis; Time Factors; Treatment Failure; Triglycerides	1995
Effect of miglitol (BAY m-1099) on fasting blood glucose in type 2 diabetes mellitus. The Netherlands journal of medicine, 1994, Volume: 44, Issue:6 Topics: 1-Deoxynojirimycin; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Male; Middle Aged	1994
Effects of the carbohydrase inhibitor miglitol in sulfonylurea-treated NIDDM patients. Diabetes care, 1994, Volume: 17, Issue:1 Topics: 1-Deoxynojirimycin; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Lipids; Male; Middle Aged; Time Factors	1994
Does suppression of postprandial blood glucose excursions by the alpha-glucosidase inhibitor miglitol improve insulin sensitivity in diet-treated type II diabetic patients? Diabetes care, 1996, Volume: 19, Issue:6 Topics: 1-Deoxynojirimycin; Biomarkers; Blood Glucose; Cholesterol; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Method; Enzyme Inhibitors; Female; Fructosamine; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Male; Metabolic Clearance Rate; Middle Aged; Triglycerides	1996
Study of the effect of miglitol on the pharmacokinetics and pharmacodynamics of warfarin in healthy males. Arzneimittel-Forschung, 1996, Volume: 46, Issue:1 Topics: 1-Deoxynojirimycin; Adult; Anticoagulants; Blood Coagulation; Cross-Over Studies; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Glucosamine; Glucosidases; Humans; Imino Pyranoses; Male; Stereoisomerism; Warfarin	1996
Miglitol (Bay m 1099) has no extraintestinal effects on glucose control in healthy volunteers. British journal of clinical pharmacology, 1996, Volume: 42, Issue:4 Topics: 1-Deoxynojirimycin; Adult; Area Under Curve; Blood Glucose; C-Peptide; Double-Blind Method; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Intestine, Small; Male; Placebos	1996
The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone. Diabetes care, 1997, Volume: 20, Issue:5 Topics: 1-Deoxynojirimycin; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diarrhea; Diet, Diabetic; Double-Blind Method; Enzyme Inhibitors; Fasting; Female; Flatulence; Glucosamine; Glyburide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemia; Hypoglycemic Agents; Imino Pyranoses; Male; Middle Aged; Placebos; Postprandial Period	1997
Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man. Arzneimittel-Forschung, 1997, Volume: 47, Issue:6 Topics: 1-Deoxynojirimycin; Administration, Oral; Animals; Autoradiography; Blood Proteins; Dogs; Duodenum; Enzyme Inhibitors; Feces; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Injections, Intravenous; Male; Milk; Placenta; Pregnancy; Protein Binding; Rats; Rats, Sprague-Dawley; Rats, Wistar; Species Specificity; Tissue Distribution	1997
Long-term titrated-dose alpha-glucosidase inhibition in non-insulin-requiring Hispanic NIDDM patients. Diabetes care, 1998, Volume: 21, Issue:3 Topics: 1-Deoxynojirimycin; Albuminuria; Blood Glucose; Creatinine; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Enzyme Inhibitors; Female; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Hispanic or Latino; Humans; Imino Pyranoses; Insulin; Lipids; Male; Middle Aged; Placebos; Postprandial Period; Time Factors; Treatment Outcome	1998
Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibition. Diabetes care, 1998, Volume: 21, Issue:3 Topics: 1-Deoxynojirimycin; Black People; Blood Glucose; Cholesterol, LDL; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Enzyme Inhibitors; Female; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Male; Middle Aged; Placebos; Postprandial Period; Single-Blind Method; Sulfonylurea Compounds; Treatment Outcome; Triglycerides	1998
Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients. The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:5 Topics: 1-Deoxynojirimycin; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Fasting; Female; Food; Glucosamine; Glyburide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Kinetics; Male	1998
Long-term effectiveness of a new alpha-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated type 2 diabetes mellitus. Diabetic medicine : a journal of the British Diabetic Association, 1998, Volume: 15, Issue:8 Topics: 1-Deoxynojirimycin; Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Fasting; Female; Follow-Up Studies; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Male; Middle Aged; Postprandial Period; Time Factors	1998
[Alpha-glucosidase inhibitor for type 2 diabetic patients. Clinical study with miglitol]. MMW Fortschritte der Medizin, 2000, May-25, Volume: 142, Issue:21 Topics: 1-Deoxynojirimycin; Diabetes Mellitus, Type 2; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin Resistance	2000
Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics. Diabetes research and clinical practice, 2001, Volume: 51, Issue:3 Topics: 1-Deoxynojirimycin; Analysis of Variance; Blood Glucose; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Method; Drug Therapy, Combination; Female; Glucosamine; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Imino Pyranoses; Male; Metformin; Middle Aged; Placebos	2001
The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes. Diabetes care, 2001, Volume: 24, Issue:6 Topics: 1-Deoxynojirimycin; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Fasting; Female; Glucosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Male; Metformin; Middle Aged; Placebos; Postprandial Period; Racial Groups	2001
Miglitol combined with metformin improves glycaemic control in type 2 diabetes. Diabetes, obesity & metabolism, 2001, Volume: 3, Issue:5 Topics: 1-Deoxynojirimycin; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Glucosamine; Humans; Hypoglycemic Agents; Imino Pyranoses; Male; Metformin; Middle Aged; Single-Blind Method	2001
Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study. Diabetes, nutrition & metabolism, 2002, Volume: 15, Issue:3 Topics: 1-Deoxynojirimycin; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Food; Gastrointestinal Diseases; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Male; Middle Aged; Placebos	2002
The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics. Diabetes, obesity & metabolism, 2002, Volume: 4, Issue:5 Topics: 1-Deoxynojirimycin; Adult; Aged; Appetite; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucosamine; Humans; Hypoglycemic Agents; Imino Pyranoses; Middle Aged; Obesity; Peptide Fragments; Postprandial Period; Protein Precursors	2002
HbA(1c) and glycemic profile, basal- and post-treatment with Miglitol, in an area with a Mediterranean diet. Diabetes care, 2002, Volume: 25, Issue:10 Topics: 1-Deoxynojirimycin; Blood Glucose; Diabetes Mellitus, Type 2; Diet; Diet, Diabetic; Fasting; Glucosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Mediterranean Region; Postprandial Period; Regression Analysis	2002

Other Studies

43 other study(ies) available for glucosamine and miglitol

Article	Year
The effects of low-dose Bay-m-1099 (Miglitol) on serum lipids and liver enzyme activity of obese and obese-diabetic corpulent rats. Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology, 1991, Volume: 99, Issue:1-2 Topics: 1-Deoxynojirimycin; Adipose Tissue; Animals; Blood Glucose; Blood Proteins; Diabetes Mellitus; Glucokinase; Glucosamine; Glucosephosphate Dehydrogenase; Glycoside Hydrolase Inhibitors; Imino Pyranoses; Insulin; Lipids; Liver; Obesity; Phenotype; Rats; Weight Gain	1991
Lysosomal storage of glycogen as a sequel of alpha-glucosidase inhibition by the absorbed deoxynojirimycin derivative emiglitate (BAYo1248). A drug-induced pattern of hepatic glycogen storage mimicking Pompe's disease (glycogenosis type II). Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1991, Volume: 191, Issue:6 Topics: 1-Deoxynojirimycin; Acarbose; Animals; Female; Glucosamine; Glycogen Storage Disease Type II; Glycoside Hydrolase Inhibitors; Imino Pyranoses; Liver; Liver Glycogen; Lysosomes; Microscopy, Electron; Rats; Rats, Inbred Strains; Trisaccharides	1991
[Inhibitor of carbohydrate metabolism (inhibitor of gluconeogenesis, disaccharidase inhibitor)]. Nihon rinsho. Japanese journal of clinical medicine, 1991, Volume: 49, Issue:9 Topics: 1-Deoxynojirimycin; 3-Mercaptopropionic Acid; Acarbose; Animals; Carbohydrate Metabolism; Cyclohexanols; Cycloserine; Disaccharidases; Gluconeogenesis; Glucosamine; Humans; Hydrazines; Imino Pyranoses; Liver; Oleic Acids; Trisaccharides	1991
Effects of alpha-glucosidase inhibition on meal glucose tolerance and timing of insulin administration in patients with type I diabetes mellitus. Diabetes care, 1991, Volume: 14, Issue:5 Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Eating; Energy Intake; Glucosamine; Glucose Clamp Technique; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Male	1991
Effect of the alpha-glucosidase inhibitor N-hydroxyethyl-1-deoxynojirimycin (Bay m 1099) on the biosynthesis of liver secretory glycoproteins. Biochemical pharmacology, 1989, Aug-01, Volume: 38, Issue:15 Topics: 1-Deoxynojirimycin; Acetylglucosaminidase; alpha 1-Antitrypsin; Animals; Electrophoresis, Polyacrylamide Gel; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Imino Pyranoses; In Vitro Techniques; Liver; Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase; Orosomucoid; Precipitin Tests; Rats; Rats, Inbred Strains	1989
Effects of N-hydroxyethyl-1-deoxynojirimycin (BAY m 1099) on the activity of neutral- and acid alpha-glucosidases in human fibroblasts and HepG2 cells. Clinica chimica acta; international journal of clinical chemistry, 1989, Jun-15, Volume: 182, Issue:1 Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Binding, Competitive; Carcinoma, Hepatocellular; Fibroblasts; Glucosamine; Glycogen; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Immunohistochemistry; Kinetics; Liver Neoplasms; Lysosomes; Microscopy, Electron; Molecular Weight; Tumor Cells, Cultured	1989
Metabolic consequences of the alpha-glucosidase inhibitor BAY-M-1099 given to nondiabetic and diabetic rats fed a high-carbohydrate diet. The American journal of clinical nutrition, 1989, Volume: 49, Issue:1 Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diet; Dietary Carbohydrates; Glucosamine; Glycoside Hydrolase Inhibitors; Glycosuria; Imino Pyranoses; Male; Rats; Rats, Inbred Strains; Sucrose; Triglycerides	1989
The effect of acarbose and miglitol (BAY-M-1099) on postprandial glucose levels following ingestion of various sources of starch by nondiabetic and streptozotocin-induced diabetic rats. The Journal of nutrition, 1989, Volume: 119, Issue:12 Topics: 1-Deoxynojirimycin; Acarbose; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Eating; Glucosamine; Glucose; Glucosidases; Imino Pyranoses; Insulin; Male; Rats; Starch; Trisaccharides	1989
Inhibitory mechanism of acarbose and 1-deoxynojirimycin derivatives on carbohydrases in rat small intestine. Drugs under experimental and clinical research, 1987, Volume: 13, Issue:8 Topics: 1-Deoxynojirimycin; Acarbose; alpha-Amylases; Animals; Anti-Bacterial Agents; Female; Glucosamine; Glycoside Hydrolases; Hypoglycemic Agents; Imino Pyranoses; In Vitro Techniques; Intestine, Small; Kinetics; Microvilli; Pancreas; Rats; Rats, Inbred Strains; Trisaccharides	1987
1-Deoxynojirimycin and related compounds inhibit glycogenolysis in the liver without affecting the concentration of phosphorylase a. Biochemical pharmacology, 1988, Mar-01, Volume: 37, Issue:5 Topics: 1-Deoxynojirimycin; Animals; Dose-Response Relationship, Drug; Glucagon; Glucosamine; Glycogen Synthase; Glycoside Hydrolase Inhibitors; Imino Pyranoses; Liver; Liver Glycogen; Male; Phosphorylase a; Phosphorylases; Rats; Rats, Inbred Strains; Structure-Activity Relationship	1988
Effect of alpha-inhibitors on blood glucose and insulin levels. Advances in experimental medicine and biology, 1988, Volume: 246 Topics: 1-Deoxynojirimycin; Acarbose; Aged; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Middle Aged; Obesity; Reference Values; Trisaccharides	1988
Alpha-glucosidase inhibition and timing of preprandial insulin in patients with insulin-dependent diabetes mellitus (IDDM). Diabetes research and clinical practice, 1988, Apr-06, Volume: 4, Issue:4 Topics: 1-Deoxynojirimycin; Blood Glucose; Diabetes Mellitus, Type 1; Drug Administration Schedule; Eating; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Imino Pyranoses; Insulin; Kinetics; Male	1988
Adaptive responses to pharmacological inhibition of small intestinal alpha-glucosidases in the rat. Gut, 1987, Volume: 28 Suppl Topics: 1-Deoxynojirimycin; Adaptation, Physiological; Animals; Cecum; Female; Glucosamine; Glycoside Hydrolase Inhibitors; Imino Pyranoses; Intestine, Small; Organ Size; Polyamines; Rats; Rats, Inbred Strains	1987
Effect of an alpha-glucosidase inhibitor (BAY m 1099) on post-prandial blood glucose and insulin in type II diabetics. European journal of clinical pharmacology, 1986, Volume: 30, Issue:2 Topics: 1-Deoxynojirimycin; Adult; Aged; Anti-Bacterial Agents; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucosamine; Humans; Imino Pyranoses; Insulin; Male; Middle Aged	1986
Miglitol may have a blood glucose lowering effect unrelated to inhibition of alpha-glucosidase. European journal of clinical pharmacology, 1987, Volume: 31, Issue:6 Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Male	1987
Regulation of the absorption of dietary carbohydrate in man by two new glycosidase inhibitors. Gut, 1986, Volume: 27, Issue:12 Topics: 1-Deoxynojirimycin; Adult; Blood Glucose; Dietary Carbohydrates; Dose-Response Relationship, Drug; Glucosamine; Glycoside Hydrolases; Humans; Hydrogen; Imino Pyranoses; Intestinal Absorption; Male; Maltose; Starch; Substrate Specificity; Sucrose	1986
Effect of 1-desoxynojirimycin derivatives on small intestinal disaccharidase activities and on active transport in vitro. Digestion, 1985, Volume: 31, Issue:2-3 Topics: 1-Deoxynojirimycin; Alkaline Phosphatase; Animals; Anti-Bacterial Agents; Biological Transport, Active; Disaccharidases; Female; Glucosamine; Imino Pyranoses; In Vitro Techniques; Intestinal Mucosa; Intestine, Small; Leucine; Methylglucosides; Rats; Rats, Inbred Strains	1985
Ca2+ deficiency, selective alpha-glucosidehydrolase inhibition, and insulin secretion. The American journal of physiology, 1993, Volume: 265, Issue:1 Pt 1 Topics: 1-Deoxynojirimycin; 1-Methyl-3-isobutylxanthine; Animals; Calcium; Dose-Response Relationship, Drug; Female; Glucosamine; Glucose; Glycoside Hydrolase Inhibitors; Imino Pyranoses; Insulin; Insulin Secretion; Islets of Langerhans; Lysosomes; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Muscular Dystrophy, Animal	1993
The effects of the intestinal glucosidase inhibitory BAY M 1099 (miglitol) on glycemic status of obese-diabetic rats. General pharmacology, 1993, Volume: 24, Issue:2 Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Type 2; Eating; Glucosamine; Glycoside Hydrolase Inhibitors; Imino Pyranoses; Male; Obesity; Rats; Rats, Inbred SHR	1993
In vitro study of the effect of miglitol on carbohydrate digestion and intestinal metabolism in normal and non-insulin-dependent diabetic rats. Canadian journal of physiology and pharmacology, 1996, Volume: 74, Issue:11 Topics: 1-Deoxynojirimycin; Animals; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucosamine; Glycoside Hydrolase Inhibitors; Imino Pyranoses; In Vitro Techniques; Intestinal Absorption; Intestine, Small; Male; Perfusion; Rats; Rats, Wistar	1996
Effect of miglitol administration to non-insulin-dependent diabetic rats. General pharmacology, 1998, Volume: 30, Issue:1 Topics: 1-Deoxynojirimycin; Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Enzyme Inhibitors; Glucosamine; Hypoglycemic Agents; Imino Pyranoses; Male; Rats; Rats, Wistar	1998
Miglitol (BAY m 1099) treatment of diabetic hypothalamic-dietary obese rats improves islet response to glucose. Obesity research, 1999, Volume: 7, Issue:1 Topics: 1-Deoxynojirimycin; Animal Feed; Animals; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Glucosamine; Glucose; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Imino Pyranoses; Insulin; Insulin Secretion; Islets of Langerhans; Obesity; Rats; Rats, Sprague-Dawley; Ventromedial Hypothalamic Nucleus	1999
Miglitol for type 2 diabetes mellitus. The Medical letter on drugs and therapeutics, 1999, May-21, Volume: 41, Issue:1053 Topics: 1-Deoxynojirimycin; Diabetes Mellitus, Type 2; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses	1999
Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099). Metabolism: clinical and experimental, 1999, Volume: 48, Issue:6 Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Body Weight; Disease Models, Animal; Eating; Enzyme Inhibitors; Glucosamine; Glucose Tolerance Test; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Imino Pyranoses; Insulin; Insulin Resistance; Lipids; Male; Obesity; Postprandial Period; Rats	1999
A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits. British journal of pharmacology, 1999, Volume: 128, Issue:8 Topics: 1-Deoxynojirimycin; Animals; Dose-Response Relationship, Drug; Glucosamine; Glycogen; Hemodynamics; Hypoglycemic Agents; Imino Pyranoses; Lactic Acid; Male; Myocardial Infarction; Myocardium; Rabbits	1999
[Drug therapy of type 2 diabetes: insulin sensitizers improve results]. Pflege Zeitschrift, 1999, Volume: 52, Issue:11 Topics: 1-Deoxynojirimycin; Acarbose; Diabetes Mellitus, Type 2; Diet Therapy; Diet, Diabetic; Drug Therapy, Combination; Glucosamine; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin	1999
[Risk of complications in the diabetic patient. Postprandial blood glucose peaks as deciding factor]. MMW Fortschritte der Medizin, 2000, Jul-06, Volume: 142, Issue:26-27 Topics: 1-Deoxynojirimycin; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Glucosamine; Humans; Hypoglycemic Agents; Imino Pyranoses	2000
Miglitol and hepatotoxicity in type 2 diabetes mellitus. American family physician, 2000, Jul-15, Volume: 62, Issue:2 Topics: 1-Deoxynojirimycin; Acarbose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Liver; Liver Function Tests; Transaminases	2000
Similarity in the linear and non-linear oral absorption of drugs between human and rat. International journal of clinical pharmacology and therapeutics, 2000, Volume: 38, Issue:11 Topics: 1-Deoxynojirimycin; Acyclovir; Administration, Oral; Animals; Chlorothiazide; Glucosamine; Humans; Imino Pyranoses; Intestinal Absorption; Propanolamines; Rats; Species Specificity	2000
A new era in type 2 diabetes mellitus treatment? The American journal of medicine, 2001, Volume: 111, Issue:1 Topics: 1-Deoxynojirimycin; Acarbose; Carbamates; Diabetes Mellitus, Type 2; Glucosamine; Humans; Hypoglycemic Agents; Imino Pyranoses; Multicenter Studies as Topic; Pioglitazone; Piperidines; Randomized Controlled Trials as Topic; Thiazoles; Thiazolidinediones	2001
Combination of miglitol, an anti-diabetic drug, and nicorandil markedly reduces myocardial infarct size through opening the mitochondrial K(ATP) channels in rabbits. British journal of pharmacology, 2001, Volume: 133, Issue:7 Topics: 1-Deoxynojirimycin; Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Blood Pressure; Decanoic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucosamine; Heart Rate; Hemodynamics; Hydroxy Acids; Hypoglycemic Agents; Imino Pyranoses; Male; Mitochondria, Heart; Myocardial Infarction; Nicorandil; Potassium Channels; Rabbits	2001
[Alpha-glucosidase inhibitor in type 2 diabetic patients. Metabolism and body weight are favorably modified]. MMW Fortschritte der Medizin, 2001, Apr-26, Volume: 143, Issue:17 Topics: 1-Deoxynojirimycin; Body Weight; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Energy Metabolism; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses	2001
Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents. Diabetes care, 2002, Volume: 25, Issue:1 Topics: 1-Deoxynojirimycin; Administration, Oral; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Intestinal Absorption	2002
[Therapy decision based on the glucose triad. Drug treatment of type 2 diabetes]. MMW Fortschritte der Medizin, 2003, Feb-27, Volume: 145, Issue:9 Topics: 1-Deoxynojirimycin; Acarbose; Administration, Oral; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Glucosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Imino Pyranoses; Insulin; Insulin Resistance; Insulin Secretion; Metformin; Obesity; Pioglitazone; Risk Factors; Rosiglitazone; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Time Factors	2003
[Usefulness of miglitol in patients with diabetes mellitus type 2 and insufficient control of the blood glucose]. Revista clinica espanola, 2004, Volume: 204, Issue:1 Topics: 1-Deoxynojirimycin; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Glucosamine; Humans; Hyperlipidemias; Hypoglycemic Agents; Imino Pyranoses; Lipids; Male; Middle Aged; Treatment Outcome	2004
Antidiabetic drug miglitol inhibits myocardial apoptosis involving decreased hydroxyl radical production and Bax expression in an ischaemia/reperfusion rabbit heart. British journal of pharmacology, 2004, Volume: 142, Issue:6 Topics: 1-Deoxynojirimycin; Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Blood Pressure; Blotting, Western; DNA Fragmentation; Electrophoresis, Agar Gel; Gentisates; Glucosamine; Heart Rate; Hemodynamics; Hydroxyl Radical; Hypoglycemic Agents; Imino Pyranoses; Immunohistochemistry; In Situ Nick-End Labeling; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Proto-Oncogene Proteins c-bcl-2; Rabbits; Time Factors	2004
[Treatment of type 2 diabetes mellitus with the alpha-glucosidase inhibitor Miglitol in the doctor's office]. Fortschritte der Medizin. Originalien, 2000, Jul-27, Volume: 118 Suppl 2 Topics: 1-Deoxynojirimycin; Adult; Age Factors; Aged; Aged, 80 and over; Blood Glucose; Diabetes Mellitus, Type 2; Family Practice; Feasibility Studies; Female; Follow-Up Studies; Glucosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Imino Pyranoses; Internal Medicine; Male; Middle Aged; Patient Compliance; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Weight Loss	2000
[The alpha-glucosidase inhibitor miglitol for the treatment of type 2 diabetes mellitus in the doctor's office]. Fortschritte der Medizin. Originalien, 2001, Jul-19, Volume: 119 Suppl 2 Topics: 1-Deoxynojirimycin; Adult; Aged; Aged, 80 and over; Blood Glucose; Body Mass Index; Body Weight; Diabetes Mellitus, Type 2; Female; Glucosamine; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Male; Middle Aged; Safety; Time Factors; Triglycerides	2001
The anti-diabetic drug miglitol is protective against anginal ischaemia through a mechanism independent of regional myocardial blood flow in the dog. Clinical and experimental pharmacology & physiology, 2005, Volume: 32, Issue:10 Topics: 1-Deoxynojirimycin; Angina Pectoris; Animals; Blood Glucose; Blood Pressure; Coronary Circulation; Dogs; Glucosamine; Heart Rate; Hypoglycemic Agents; Imino Pyranoses; Lactates; Male; Myocardial Ischemia; Myocardium	2005
[Pharmacokinetic, pharmacological, and clinical profile of miglitol (SEIBULE), a novel alpha-glucosidase inhibitor]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2006, Volume: 127, Issue:3 Topics: 1-Deoxynojirimycin; Animals; Diabetes Mellitus, Type 2; Dogs; Glucosamine; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Imino Pyranoses; Rats	2006
Liquid chromatographic tandem mass spectrometry method for the quantification of miglitol in human plasma. Arzneimittel-Forschung, 2006, Volume: 56, Issue:5 Topics: 1-Deoxynojirimycin; Biological Availability; Chromatography, Liquid; Glucosamine; Half-Life; Humans; Hypoglycemic Agents; Imino Pyranoses; Magnetic Resonance Spectroscopy; Mass Spectrometry; Reproducibility of Results; Therapeutic Equivalency	2006
Isolation and SAR studies of bicyclic iminosugars from Castanospermum australe as glycosidase inhibitors. Phytochemistry, 2015, Volume: 111 Topics: 1-Deoxynojirimycin; Alkaloids; Castanospermum; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolases; Hypoglycemic Agents; Imino Sugars; Indolizines; Piperidines; Stereoisomerism; Structure-Activity Relationship	2015
Supramolecular azasugar clusters based on an amphiphilic fatty-acid-deoxynojirimycin derivative as multivalent glycosidase inhibitors. Journal of materials chemistry. B, 2019, 03-07, Volume: 7, Issue:9 Topics: 1-Deoxynojirimycin; alpha-Mannosidase; Animals; Blood Glucose; Cell Survival; Enzyme Inhibitors; Fatty Acids; Glucosamine; Glucose Tolerance Test; Hydrogen-Ion Concentration; Hypoglycemic Agents; Maltose; Mice	2019

chemdatabank.com